From Genomic Alterations to Functional Tumor Biology: Integrating Organoids and Organ‐on‐a‐Chip in Colorectal Cancer
Biology of the Cell · 2026-06 · 118 (6)
DOI: 10.1111/boc.70072 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biology of the Cell, online erschienen am 24.06.2026. Verfasst von Woei-Yau Kao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology‑Oncology, Department of Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Organoids, Genomics, Lab-On-A-Chip Devices. Die Arbeit nennt 107 Literaturangaben. Gefördert von: Taipei Tzu Chi Hospital.
Abstract (Originalsprache)
Colorectal cancer (CRC) develops through the stepwise accumulation of genetic alterations, including mutations in APC , KRAS , and TP53 , which drive tumor initiation and progression. Although advances in genomic profiling have significantly improved our understanding of CRC, translating these alterations into functional outcomes and therapeutic responses remains a major challenge. This limitation arises from tumor heterogeneity, context‐dependent signaling, and the dynamic nature of tumor evolution. Recent advances in patient‐derived organoids (PDOs) have provided a platform that preserves tumor‐specific architecture and genetic features, enabling functional interrogation of drug responses. However, PDOs lack critical components of the tumor microenvironment, such as stromal, immune, and mechanical cues. Organ‐on‐a‐chip (OoC) technologies, particularly organoid‐on‐a‐chip systems in which PDOs are integrated into microfluidic devices, further address these limitations by recapitulating physiological conditions and multicellular interactions. In this review, we discuss the genetic evolution of CRC and highlight how emerging functional models, including PDOs and organoid‐on‐a‐chip platforms, bridge the gap between genomic alterations and tumor behavior. We propose that integrating these platforms offers a promising framework for advancing functional precision medicine and improving our understanding of CRC biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology‑Oncology, Department of Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
- School of Medicine, Tzu Chi University, Hualien, Taiwan.
- National Center for Biomodels, National Institutes of Applied Research, Taipei, Taiwan.
- Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
ORCID-Profile: Woei-Yau Kao, Lu-Kai Wang, Fu-Ming Tsai
Förderung
- Taipei Tzu Chi Hospital
Zitieren
APA
Kao, W. Y., Wang, L. K., & Tsai, F. M. (2026). From Genomic Alterations to Functional Tumor Biology: Integrating Organoids and Organ‐on‐a‐Chip in Colorectal Cancer. Biology of the Cell, 118(6). https://doi.org/10.1111/boc.70072
Vancouver
Kao WY, Wang LK, Tsai FM. From Genomic Alterations to Functional Tumor Biology: Integrating Organoids and Organ‐on‐a‐Chip in Colorectal Cancer. Biology of the Cell. 2026;118(6). doi:10.1111/boc.70072
BibTeX
@article{Kao2026,
author = {Kao, Woei-Yau and Wang, Lu-Kai and Tsai, Fu-Ming},
title = {From Genomic Alterations to Functional Tumor Biology: Integrating Organoids and Organ‐on‐a‐Chip in Colorectal Cancer},
journal = {Biology of the Cell},
year = {2026},
volume = {118},
number = {6},
doi = {10.1111/boc.70072}
}
EUVIMED